Thomas H Connor1, Christina C Lawson, Martha Polovich, Melissa A McDiarmid. 1. From THC-Research Biologist, Division of Applied Research and Technology (Dr Connor) and CCL-Lead Health Scientist, Division of Surveillance Hazard Evaluations & Field Studies (Dr Lawson), National Institute for Occupational Safety and Health, Cincinnati, Ohio; Clinical Associate Professor, Byrdine F. Lewis School of Nursing and Health Professions (Dr Polovich), Georgia State University, Atlanta; and Division of Occupational and Environmental Medicine (Dr McDiarmid), University of Maryland School of Medicine, Baltimore.
Abstract
OBJECTIVES: Antineoplastic drugs are known reproductive and developmental toxicants. Our objective was to review the existing literature of reproductive health risks to workers who handle antineoplastic drugs. METHODS: A structured literature review of 18 peer-reviewed, English language publications of occupational exposure and reproductive outcomes was performed. RESULTS: Although effect sizes varied with study size and population, occupational exposure to antineoplastic drugs seems to raise the risk of both congenital malformations and miscarriage. Studies of infertility and time to pregnancy also suggested an increased risk for subfertility. CONCLUSIONS: Antineoplastic drugs are highly toxic in patients receiving treatment, and adverse reproductive effects have been well documented in these patients. Health care workers with long-term, low-level occupational exposure to these drugs also seem to have an increased risk of adverse reproductive outcomes. Additional precautions to prevent exposure should be considered.
OBJECTIVES: Antineoplastic drugs are known reproductive and developmental toxicants. Our objective was to review the existing literature of reproductive health risks to workers who handle antineoplastic drugs. METHODS: A structured literature review of 18 peer-reviewed, English language publications of occupational exposure and reproductive outcomes was performed. RESULTS: Although effect sizes varied with study size and population, occupational exposure to antineoplastic drugs seems to raise the risk of both congenital malformations and miscarriage. Studies of infertility and time to pregnancy also suggested an increased risk for subfertility. CONCLUSIONS: Antineoplastic drugs are highly toxic in patients receiving treatment, and adverse reproductive effects have been well documented in these patients. Health care workers with long-term, low-level occupational exposure to these drugs also seem to have an increased risk of adverse reproductive outcomes. Additional precautions to prevent exposure should be considered.
Authors: Christina C Lawson; Carissa M Rocheleau; Elizabeth A Whelan; Eileen N Lividoti Hibert; Barbara Grajewski; Donna Spiegelman; Janet W Rich-Edwards Journal: Am J Obstet Gynecol Date: 2011-12-30 Impact factor: 8.661
Authors: Brady P Selig; James R Furr; Ryan W Huey; Colin Moran; Vinod N Alluri; Gregory R Medders; Christina D Mumm; H Gene Hallford; John J Mulvihill Journal: Birth Defects Res A Clin Mol Teratol Date: 2012-07-31
Authors: Verena Segner; Renate Kimbel; Philipp Jochems; André Heinemann; Stephan Letzel; Daniel Wollschläger; Bernd Roßbach Journal: Int Arch Occup Environ Health Date: 2017-01-16 Impact factor: 3.015
Authors: Feiby L Nassan; Christina C Lawson; Audrey J Gaskins; Candice Y Johnson; James M Boiano; Janet W Rich-Edwards; Jorge E Chavarro Journal: Am J Ind Med Date: 2019-06-20 Impact factor: 2.214
Authors: AnnMarie L Walton; Shawn Kneipp; Laura Linnan; Josephine Asafu-Adjei; Christian Douglas; Maija Leff; Bonnie Rogers Journal: Oncol Nurs Forum Date: 2019-11-01 Impact factor: 2.172